Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BLCO

Bausch plus Lomb (BLCO)

Bausch plus Lomb Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:BLCO
DateTimeSourceHeadlineSymbolCompany
07/11/202412:05PMBusiness WireBausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31NYSE:BLCOBausch plus Lomb Corporation
07/08/20247:00AMBusiness WireMillions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find ReliefNYSE:BLCOBausch plus Lomb Corporation
06/18/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
06/17/20247:00AMBusiness WireBausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 CongressNYSE:BLCOBausch plus Lomb Corporation
06/10/20247:00AMBusiness WireBausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United StatesNYSE:BLCOBausch plus Lomb Corporation
06/03/20247:00AMBusiness WireBausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United StatesNYSE:BLCOBausch plus Lomb Corporation
05/29/20244:44PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
05/29/20244:30PMBusiness WireBausch + Lomb Announces 2024 Annual Meeting of Shareholder ResultsNYSE:BLCOBausch plus Lomb Corporation
05/28/20249:00AMBusiness WireBausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®NYSE:BLCOBausch plus Lomb Corporation
05/28/20246:59AMBusiness WireBausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular LensNYSE:BLCOBausch plus Lomb Corporation
05/07/20249:09AMIH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:BLCOBausch plus Lomb Corporation
05/06/20244:34PMIH Market NewsU.S. Stocks See Further Upside Amid Renewed Interest Rate OptimismNYSE:BLCOBausch plus Lomb Corporation
05/01/20246:58AMBusiness WireBausch + Lomb Announces First-Quarter 2024 ResultsNYSE:BLCOBausch plus Lomb Corporation
04/29/20247:00AMBusiness WireBausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
04/25/20248:30AMBusiness WireBausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry EyesNYSE:BLCOBausch plus Lomb Corporation
04/18/20247:00AMBusiness WireBausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling ProgramsNYSE:BLCOBausch plus Lomb Corporation
04/15/202412:00PMBusiness WireBausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1NYSE:BLCOBausch plus Lomb Corporation
03/27/20247:00AMBusiness WireBausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual MeetingNYSE:BLCOBausch plus Lomb Corporation
03/04/20245:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
03/04/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
03/04/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
03/01/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
03/01/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
03/01/20244:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
03/01/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BLCOBausch plus Lomb Corporation
02/28/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
02/28/20248:00AMBusiness WireBausch + Lomb Announces Appointment of Karen L. Ling to Board of DirectorsNYSE:BLCOBausch plus Lomb Corporation
02/21/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:BLCOBausch plus Lomb Corporation
02/21/20247:00AMGlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:BLCOBausch plus Lomb Corporation
02/21/20246:58AMBusiness WireBausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 GuidanceNYSE:BLCOBausch plus Lomb Corporation
 Showing the most relevant articles for your search:NYSE:BLCO